Thyroid, Unspecified
Generic Name: thyroid, unspecified
Brand Names:
Thyroid
DESCRIPTION Thyroid Tablets, USP* for oral use is a natural preparation derived from porcine thyroid glands and may have a strong, characteristic odor. (T3 liothyronine is approximately four times as potent as T4 levothyroxine on a microgram for microgram basis.) They provide 38 mcg levothyroxine (T4) and 9 mcg liothyronine (T3) per grain of thyroid. The inactive ingredients are microcrystalline cellulose, lactose, silicon dioxide, and magnesium stearate.
Overview
DESCRIPTION Thyroid Tablets, USP* for oral use is a natural preparation derived from porcine thyroid glands and may have a strong, characteristic odor. (T3 liothyronine is approximately four times as potent as T4 levothyroxine on a microgram for microgram basis.) They provide 38 mcg levothyroxine (T4) and 9 mcg liothyronine (T3) per grain of thyroid. The inactive ingredients are microcrystalline cellulose, lactose, silicon dioxide, and magnesium stearate.
Uses
INDICATIONS AND USAGE Thyroid Tablets, USP are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). 2.
Dosage
DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in every case be individualized according to patient response and laboratory findings. Thyroid hormones are given orally. In acute, emergency conditions, injectable levothyroxine sodium (T4) may be given intravenously when oral administration is not feasible or desirable, as in the treatment of myxedema coma, or during total parenteral nutrition. Intramuscular administration is not advisable because of reported poor absorption. Hypothyroidism Therapy is usually instituted using low doses, with increments which depend on the cardiovascular status of the patient. The usual starting dose is 30 mg Thyroid Tablets, USP, with increments of 15 mg every 2 to 3 weeks.
Side Effects
ADVERSE REACTIONS Adverse reactions other than those indicative of hyperthyroidism because of therapeutic overdosage, either initially or during the maintenance period, are rare (See OVERDOSAGE ).
Interactions
Drug Interactions Oral Anticoagulants—Thyroid hormones appear to increase catabolism of vitamin K-dependent clotting factors. If oral anticoagulants are also being given, compensatory increases in clotting factor synthesis are impaired. Patients stabilized on oral anticoagulants who are found to require thyroid replacement therapy should be watched very closely when thyroid is started. If a patient is truly hypothyroid, it is likely that a reduction in anticoagulant dosage will be required. No special precautions appear to be necessary when oral anticoagulant therapy is begun in a patient already stabilized on maintenance thyroid replacement therapy. Insulin or Oral Hypoglycemics—Initiating thyroid replacement therapy may cause increases in insulin or oral hypoglycemic requirements.
Warnings
WARNINGS Drugs with thyroid hormone activity, alone or together with other therapeutic agents, have been used for the treatment of obesity. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. The use of thyroid hormones in the therapy of obesity, alone or combined with other drugs, is unjustified and has been shown to be ineffective. Neither is their use justified for the treatment of male or female infertility unless this condition is accompanied by hypothyroidism. CONTRAINDICATIONS Thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis, and apparent hypersensitivity to any of their active or extraneous constituents. There is no well-documented evidence from the literature, however, of true allergic or idiosyncratic reactions to thyroid hormone.
Storage
HOW SUPPLIED Thyroid Tablets, USP are supplied as follows: 15 mg (1/4 grain) are available in bottles of 100 (NDC 79739-7370-1). 30 mg (1/2 grain) are available in bottles of 100 (NDC 79739-7371-1). 60 mg (1 grain) are available in bottles of 100 (NDC 79739-7372-1). 90 mg (1 & 1/2 grain) are available in bottles of 100 (NDC 79739-7373-1).
Frequently Asked Questions
What is Thyroid, Unspecified used for?▼
INDICATIONS AND USAGE Thyroid Tablets, USP are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). 2.
What are the side effects of Thyroid, Unspecified?▼
ADVERSE REACTIONS Adverse reactions other than those indicative of hyperthyroidism because of therapeutic overdosage, either initially or during the maintenance period, are rare (See OVERDOSAGE ).
What are the important warnings for Thyroid, Unspecified?▼
WARNINGS Drugs with thyroid hormone activity, alone or together with other therapeutic agents, have been used for the treatment of obesity. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. The use of thyroid hormones in the therapy of obesity, alone or combined with other drugs, is unjustified and has been shown to be ineffective. Neither is their use justified for the treatment of male or female infertility unless this condition is accompanied by hypothyroidism. CONTRAINDICATIONS Thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis, and apparent hypersensitivity to any of their active or extraneous constituents. There is no well-documented evidence from the literature, however, of true allergic or idiosyncratic reactions to thyroid hormone.
Related Medications
Aconitum Napellus, Allium Cepa, Bryonia, Echinacea Angustifolia, Eupatorium Perfoliatum, Euphrasia Officinalis, Gelsemium Sempervirens, Pulsatilla, Rhus Tox
aconitum napellus, allium cepa, bryonia, echinacea angustifolia, eupatorium perfoliatum, euphrasia officinalis, gelsemium sempervirens, pulsatilla, rhus tox
Dosage form: POWDER. Active ingredients: ACONITUM NAPELLUS WHOLE (12 [hp_X]/kg); BRYONIA ALBA ROOT (9 [hp_X]/kg); ECHINACEA ANGUSTIFOLIA WHOLE (6 [hp_X]/kg); EUPATORIUM PERFOLIATUM FLOWERING TOP (6 [hp_X]/kg); EUPHRASIA STRICTA (6 [hp_X]/kg); GELSEMIUM SEMPERVIRENS ROOT (12 [hp_X]/kg); ONION (6 [hp_X]/kg); PULSATILLA VULGARIS WHOLE (9 [hp_X]/kg); TOXICODENDRON PUBESCENS LEAF (12 [hp_X]/kg). Category: DRUG FOR FURTHER PROCESSING.
Delphinium Staphisagria Seed
delphinium staphisagria seed
TRADITIONALLY USE FOR: Minor cuts & surgical wounds*
1% Clotrimazole
1% clotrimazole
Azole Antifungal [EPC]
Antifungal
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.